$0.5700
-0.0068-1.18%
Last update: Oct 29, 9:26 AM
Citius Oncology Inc
CTORNASDAQ
Citius Oncology (CTOR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.01 | $-0.04 | $-0.06 |
| Actual | $-0.08 | $-0.27 | $-0.06 | $-0.06 |
| Surprise | -14.3% | -2600.0% | -50.0% | 0.00% |
| Revenue | ||||
| Estimate | $2.5M | $7.0M | $4.4M | — |
| Actual | $1.5M | $1.7M | $3.9M | $0 |
| Surprise | -40.2% | -76.2% | -9.81% | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.19 | — |
| Revenue | ||
| Consensus | $5.8M | $14.3M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 14, 2026 | $-0.08 | $-0.07 | -14.3 % |
| Q2 | May 15, 2026 | $-0.27 | $-0.01 | -2600.0 % |
| Q1 | Feb 13, 2026 | $-0.06 | $-0.04 | -50.0 % |
| Q4 | Dec 23, 2025 | $-0.06 | $-0.06 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 14, 2026 | $1.49M | $2.50M | -40.2 % |
| Q2 | May 15, 2026 | $1.67M | $7.00M | -76.2 % |
| Q1 | Feb 13, 2026 | $3.94M | $4.37M | -9.81 % |
